Skip to main content
ARDT logo

ARDT · Ardent Health, Inc. · Documents

Track ARDT — free
$17.80 +0.12 (+0.68%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$2.51B
Shares
140.94M
Volume · Nov 13 779.54K Avg daily vol (3M) 544.41K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $6.32B up 6.0% 10-K filed Mar 16, 2026 Quarterly report FY2026 Q3 Revenue $1.62B up 3.1% 10-Q filed Nov 5, 2026 Latest results Financial results 8-K filed Nov 4, 2026 Earnings call Q3 2026 earnings call Held Nov 5, 2026
2026
Nov 12
Current report 8-K
Boone Health acquisition priced at $47 million cash

Ardent Health, Inc. agreed to acquire Boone Health for $47 million in cash, including Boone Hospital Center and 19 sites of care; closing is expected in the first quarter of 2027.

Regulation FD disclosure
3 source passages
Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced a definitive agreement to acquire Boone Health, a not-for-profit health system based in Columbia, Missouri, for a purchase price of $47 million in cash. The acquisition will include the 392-bed Boone Hospital Center, Boone Health Medical Group, 19 sites of care, related ancillary services and associated real estate. The transaction is expected to close in the first quarter of 2027, subject to customary closing conditions. Open the document at this passage
Nov 10
Investor event
Impact savings support growth into 2027

Ardent expects its multi-year Impact program to deliver at least $70 million in savings this year and provide a tailwind into 2027, when focus shifts toward smart service-line additions and disciplined M&A.

5 source passages
We do see 2027 more as a growth year around smart additions and future work around M&A activity, less around optimizing. Sure. Yeah, 100 percent, this is a multi-year. It's definitely a program, not a project, so it's going to span a number of years. Again, as we've talked about this year, delivering at least $70 million. We will absolutely see that as a tailwind going into next year, growing the, expanding the program for new opportunities. All right. Well, that's exciting, and we appreciate you guys participating this year, Ardent, and look forward to hearing more about that. Open the document at this passage
Nov 5
Earnings call
Raises 2026 EBITDA outlook and plans Kansas divestiture

Ardent Health reported third-quarter revenue of $1.62 billion and adjusted EBITDA of $138 million, raised its 2026 adjusted EBITDA outlook to $500 to $535 million, and agreed to divest its Kansas hospital ownership at 11 times EBITDA.

4 source passages
welcome you to Ardent Health's third quarter 2026 earnings conference call. We reported third quarter revenue of $1.62 billion and adjusted EBITDA of $138 million, driven by strong execution and cost discipline. we're raising the lower end of our 2026 adjusted EBITDA outlook to $500 million from $485 million while maintaining the upper end at $535 million. Ultimately, we agreed to monetize the asset at an accretive multiple of 11 times EBITDA. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
St. Francis sale set at $58.4 million

Ardent Health, Inc. agreed to sell its 70.5% equity interest in St. Francis to the University of Kansas Hospital Authority for $58.4 million; the sale is expected to close in the fourth quarter of 2026.

Revenue $1.62B ▲ 3.1% Net income $44.52M Diluted EPS $0.31
Read from the MD&A section
2 source passages
On September 28, 2026, the Company entered into a definitive agreement to sell its 70.5% equity interest in St. Francis to the University of Kansas Hospital Authority for $58.4 million. The sale is expected to close in the fourth quarter of 2026, subject to customary closing conditions. Open the document at this passage
Oct 23
Current report 8-K Events of Oct 19
Director or officer change, or executive pay

Ardent Health, Inc. reclassified Martin J. Bonick’s separation effective June 2, 2026 as termination for “Cause,” discontinuing approximately $4.5 million of unpaid cash severance and cancelling or forfeiting his outstanding unvested PRSUs; no financial results require revision.

Sep 4
Current report 8-K
Other events AI summary on its way
Aug 10
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $1.62B ▼ 1.4% Net income $16.9M ▼ 76.8% Diluted EPS $0.12 ▼ 76.9%
May 6
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $1.6B ▲ 7.0% Net income $39.85M ▼ 3.7% Diluted EPS $0.28 ▼ 3.4%
Apr 8
Proxy statement DEF 14A Meeting May 20, 2026
Proxy statement AI summary on its way
Mar 16
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $6.32B ▲ 6.0% Net income $135.81M ▼ 35.4% Diluted EPS $0.96 ▼ 39.2%
2025
Aug 6
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $1.65B ▲ 11.9% Net income $72.95M ▲ 70.6% Diluted EPS $0.52 ▲ 52.9%
May 7
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $1.5B ▲ 4.0% Net income $41.38M ▲ 53.0% Diluted EPS $0.29 ▲ 38.1%
Feb 27
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $5.97B ▲ 10.3% Net income $210.34M ▲ 290.2% Diluted EPS $1.58 ▲ 267.4%
2024
Showing 1–50 of 59 documents
Key facts CIK 1756655 CUSIP 03980N107 13F (30d) 95 filings 91 filers Visit website Investor relations